Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Davidson

Showing results (1041-1050 of 1,190) with videos related to

Pageof 119
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancerEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline updateJames L Khatcheressian, Patricia Hurley, Elissa Bantug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid TumorsMartine J Piccart, Florentine S Hilbers, Judith M Bliss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2007
Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and humanAmit S Kalgutkar, Bo Feng, Hang T Nguyen, et al.
Plant Physiology|May 11, 2012
Biosynthesis of the halogenated auxin, 4-chloroindole-3-acetic acidNathan D Tivendale, Sandra E Davidson, Noel W Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Carey K Anders, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice GuidelineAnn H Partridge, R Bryan Rumble, Lisa A Carey, et al.
Pageof 119

Showing results (1041-1050 of 1,190) with videos related to

Sort By:
Pageof 119
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancerEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Breast Cancer Research and Treatment|February 26, 2011
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancerRoisin M Connolly, Michelle A Rudek, Elizabeth Garrett-Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 7, 2012
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline updateJames L Khatcheressian, Patricia Hurley, Elissa Bantug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2020
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid TumorsMartine J Piccart, Florentine S Hilbers, Judith M Bliss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 10, 2007
Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and humanAmit S Kalgutkar, Bo Feng, Hang T Nguyen, et al.
Plant Physiology|May 11, 2012
Biosynthesis of the halogenated auxin, 4-chloroindole-3-acetic acidNathan D Tivendale, Sandra E Davidson, Noel W Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Carey K Anders, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 4, 2014
Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice GuidelineAnn H Partridge, R Bryan Rumble, Lisa A Carey, et al.
Pageof 119